메뉴 건너뛰기




Volumn 2, Issue 2, 2002, Pages 255-266

Discovery of antitumor indolocarbazoles: Rebeccamycin, NSC 655649, and fluoroindolocarbazoles

Author keywords

[No Author keywords available]

Indexed keywords

1,11 DESCHLORO 1,11 DIBROMOREBECCAMYCIN; 1,11 DICHLORO 6 (2 DIETHYLAMINOETHYL) 12,13 DIHYDRO 5H INDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE 5,7(6H) DIONE 13 (4 O METHYLGLUCOSIDE); 2 DIETHYLAMINOETHANOL; 6 FORMYLAMINO 12,13 DIHYDRO 1,11 DIHYDROXY 5H INDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE 5,7(6H) DIONE 13 GLUCOSIDE; 7 OXOSTAUROSPORINE; ANTINEOPLASTIC AGENT; AT 2433 A1; AT 2433 B1; AT2433 A1; AT2433 B1; BMS 250749; BMY 27557; BMY 27557 14; CAMPTOTHECIN; CARBAZOLE DERIVATIVE; DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); DOXORUBICIN; ETOPOSIDE; FLUOROINDOLOCARBAZOLE DERIVATIVE; INDOLOCARBAZOLE DERIVATIVE; IRINOTECAN; K 252A; K 252B; REBECCAMYCIN; SINGLE STRANDED DNA; STAUROSPORINE; STAUROSPORINE DERIVATIVE; TENIPOSIDE; TOPOTECAN; TRYPTOPHAN DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

EID: 0036080107     PISSN: 15680118     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568011023354218     Document Type: Review
Times cited : (100)

References (58)
  • 10
    • 84872266912 scopus 로고
    • Bristol-Myers Squibb Co. Rebeccamycin derivative containing pharmaceutical composition. US 4, 808, 613 (Issued: February 28,)
    • (1989)
    • Kaneko, T.1    Wong, H.S.2    Utzig, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.